Trials / Sponsors / Shanghai Vinnerna Biosciences Co., Ltd.
Shanghai Vinnerna Biosciences Co., Ltd.
Industry · 10 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Real-World Study of JT001 for COVID-19 COVID-19 | — | 2023-08-31 |
| Completed | Effect of Pharmacokinetics in Healthy Chinese Subjects The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects | Phase 1 | 2023-08-15 |
| Completed | A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function Subjects With Liver Function Injury, Normal Liver Function Subject | Phase 1 | 2023-07-28 |
| Completed | A Study in Elderly Chinese Subjects With Underlying Diseases Elderly Subjects With Underlying Diseases | Phase 1 | 2023-07-12 |
| Completed | A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function Subjects With Renal Impairment, Healthy Subjects | Phase 1 | 2023-05-08 |
| Completed | The Mass Balance Study of [14C]JT001 Healthy Subjects | Phase 1 | 2023-03-18 |
| Completed | JT001 (VV116) for the Treatment of COVID-19 Mild to Moderate COVID-19 | Phase 3 | 2022-10-21 |
| Unknown | A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient COVID-19 Patient | — | 2022-07-14 |
| Withdrawn | Evaluate the Pharmacokinetics, Safety and Tolerability of JT001 Tablets Healthy Subjects | Phase 1 | 2022-05-02 |
| Terminated | Efficacy and Safety of JT001 (VV116) Compared With Favipiravir Moderate to Severe COVID-19 | Phase 3 | 2022-03-14 |